Peizhi Ma

722 citations
21 papers · 571 indexed · 1 hit paper · h-index 10
Topics
Cancer-related molecular mechanisms research (5 papers)Circular RNAs in diseases (4 papers)Lung Cancer Treatments and Mutations (4 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Peizhi Ma

19 papers receiving 567 citations

Hit Papers

Exosomal miR-4443 promotes cisplatin resistance in non-sm...2021202620222024202150100150200

Peers

Peizhi Ma
Comparison fields: 5 of 61
  • Molecular Biology 422
  • Cancer Research 342
  • Pulmonary and Respiratory Medicine 129
  • Oncology 45
  • Neurology 32
Replace Bi Peng with:
Bi Peng China
С. В. Никулин Russia
Yuanda Liu China
Xuanzhong Wang China
Chao Wei China
Hayley C. Affronti United States
Haoliang Zhang China
Rana Elkholi United States
Peizhi Ma relative to Bi Peng China Bi Peng's profile →
Citations per field
00.5×3.6×
Bi Peng · 1×
Citations per year

Countries citing papers authored by Peizhi Ma

Since Specialization
Citations

This map shows the geographic impact of Peizhi Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peizhi Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peizhi Ma more than expected).

Fields of papers citing papers by Peizhi Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peizhi Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peizhi Ma. The network helps show where Peizhi Ma may publish in the future.

Co-authorship network of co-authors of Peizhi Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Peizhi Ma. A scholar is included among the top collaborators of Peizhi Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peizhi Ma. Peizhi Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 5
3 7
4 1
5 7
6 6
7 27
8 15
9 1
10 15
11 18
12
Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosisbreakdown →
204
13 6
14 0
15 81
16 2
17 2
18 110
19 27
20 28

About Peizhi Ma

Peizhi Ma is a scholar working on Cancer Research, Biological Psychiatry and Neurology, having authored 21 papers that have together received 571 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Cancer Research (342 citations), Biological Psychiatry (17 citations) and Molecular Biology (422 citations). Peizhi Ma has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Gang Jia, Zhiyu Song, Shundong Cang, Yuanlong Li, Fengqin Fang, Jun Sun, Wei Zhang, Hua Fan, Ming Ni and Kun Li. Their work appears in journals such as Neuroscience, Annals of Oncology and Sensors and Actuators B Chemical.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026